X4 Pharmaceuticals Inc. Stock News

NEW YORK , March 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for F, ORGO, ARLO, OIS, and XFOR. … Full story available on Benzinga.com

BOSTON, March 01, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit patients

BOSTON, Feb. 02, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit patients w

BOSTON, Jan. 19, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit people with

BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit patients w

BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit patients with diseases of the immune system, today announced that, on December 31, 2021, the Compensation Committee of X4s Board of Directors issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the 2019 Inducement Plan). The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of X4. The inducement awards consist of options to purchase an aggregate of 37,650 shares of X4s common stock. These stock awards were granted as an inducement material to the new employees entering into employment with X4 in accordance with Nasdaq Listing Rule 5635(c)(4).

Penny stocks to watch after Society Pass (NASDAQ: SOPA) skyrockets in December. The post Low Float Penny Stocks To Watch After SOPA Stock Explodes appeared first on Penny Stocks to Buy, Picks, News an

Penny stocks to watch after Society Pass (NASDAQ: SOPA) skyrockets in December. The post Low Float Penny Stocks To Watch After SOPA Stock Explodes appeared first on Penny Stocks to Buy, Picks, News an

Which biotech penny stocks are you watching right now? The post These Biotech Penny Stocks Exploded Today, Here’s Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks

During the last session, X4 Pharmaceuticals Inc. (NASDAQ:XFOR)’s traded shares were 1.29 million, with the beta value of the company hitting 0.43. At the end of the trading day, the stock’s price was $2.37, reflecting an intraday gain of 17.33% or $0.35. The 52-week high for the XFOR share is $10.70, that puts it down … X4 Pharmaceuticals Inc. (NASDAQ: XFOR) Drops -351.48% From Highs, Now What? Read More »

Which biotech penny stocks are you watching right now? The post These Biotech Penny Stocks Exploded Today, Here's Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug Calliditas Therapeutics AB (

X4 Pharmaceuticals had its price target cut by HC Wainwright from $21.00 to $11.00 in a research note published on Tuesday, The Fly reports. They currently have a buy rating on

In the last trading session, 2.47 million shares of the X4 Pharmaceuticals Inc. (NASDAQ:XFOR) were traded, and its beta was 0.44. Most recently the companys share price was $2.14, and it changed around -$1.69 or -44.13% from the last close, which brings the market valuation of the company to $59.68M. XFOR currently trades at a X4 Pharmaceuticals Inc. (NASDAQ: XFOR): A Suicide Machine Or A Millionaires Dream? Read More »